SCHEMBL19359220

SCHEMBL19359220

Nc1nccc(C(CCNC(=O)c2ccccc2)c2ccccc2)c1N

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 11/20 0.62
▸ CYP2C9 P11712 1/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ LMNA P02545 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ TPSAB1 Q15661 1/20 0.47
▸ KMT2A Q03164 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ MTNR1A P48039 1/20 0.43
▸ MTNR1B P49286 1/20 0.43
▸ CNR1 P21554 1/20 0.42
▸ CNR2 P34972 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19381378 0.82 EPHX2 (0.60) EPHX2CYP2C9CYP2C19LMNAHPGD
SCHEMBL19359257 0.82 EPHX2 (0.60) EPHX2CYP2C9CYP2C19LMNAHPGD
SCHEMBL5948102 0.78 EPHX2 (1.00) EPHX2CYP2C9CYP2C19HPGDTPSAB1
SCHEMBL5947676 0.76 EPHX2 (0.67) EPHX2CYP2C9CYP2C19LMNAHPGD
SCHEMBL5948064 0.74 EPHX2 (1.00) EPHX2CYP2C9CYP2C19LMNAHPGD
SCHEMBL5947857 0.74 EPHX2 (0.63) EPHX2CYP2C9CYP2C19LMNAHPGD
SCHEMBL19359259 0.74 EPHX2 (0.73) EPHX2CYP2C9CYP2C19LMNAHPGD
SCHEMBL4638764 0.73 EPHX2 (0.87) EPHX2CYP2C9CYP2C19LMNAHPGD
SCHEMBL5947971 0.72 EPHX2 (0.68) EPHX2CYP2C9CYP2C19LMNAHPGD
SCHEMBL5213128 0.72 EPHX2 (0.71) EPHX2CYP2C9CYP2C19LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017161145-A1 TRIAZOLOPYRIDINE INHIBITORS OF MYELOPEROXIDASE AND/OR EPX BRISTOL-MYERS SQUIBB COMPANY (US) 2017-09-21 — — WO disclosed
Send feedback